Global Genetic Testing Market Report 2020-2024: What Key Interest is Driving Direct to Consumer?
October 13, 2020 06:59 ET
|
Research and Markets
Dublin, Oct. 13, 2020 (GLOBE NEWSWIRE) -- The "The Global Genetic Testing Market by Hereditary, Newborn, NIPT, Oncology, Pharmacogenomic and Direct to Consumer, With Executive and Consultant Guides...
Worldwide NIPT Industry to 2030 - Featuring Agilent Technologies, Annoroad Gene Technology & BGI Among Others
October 12, 2020 04:49 ET
|
Research and Markets
Dublin, Oct. 12, 2020 (GLOBE NEWSWIRE) -- The "Global NIPT Market: Focus on Test Type, Platform, Method, Application, End-User, 5 Regional Data, 25 Countries' Data, Competitive Landscape, Regulatory...
Progenity to Present Precision Medicine Abstracts at American College of Gastroenterology (ACG) Virtual Annual Meeting in October
October 09, 2020 07:30 ET
|
Progenity, Inc.
SAN DIEGO, Oct. 09, 2020 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing...
Progenity Supports the Preeclampsia Foundation Call to Action to Accelerate Development and Adoption of Biomarker Tests for Preeclampsia
October 01, 2020 07:30 ET
|
Progenity, Inc.
SAN DIEGO, Oct. 01, 2020 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing...
Progenity Announces Addition to Russell 2000® Index
September 18, 2020 07:30 ET
|
Progenity, Inc.
SAN DIEGO, Sept. 18, 2020 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing...
Progenity to Participate in Two Upcoming Investor Conferences
September 02, 2020 07:30 ET
|
Progenity, Inc.
SAN DIEGO, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing...
Progenity Commends New Recommendations from ACOG and SMFM Supporting Non-Invasive Prenatal Testing (NIPT) for All Pregnancies
August 21, 2020 07:30 ET
|
Progenity, Inc.
SAN DIEGO, Aug. 21, 2020 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing...
Progenity Provides Corporate Updates and Reports Second Quarter 2020 Financial Results
August 13, 2020 16:01 ET
|
Progenity, Inc.
Completed initial public offering raising gross proceeds of $100M Reported 75 thousand tests in the second quarter, showing resiliency of business during COVID‑19 pandemic Signed first precision...
Progenity to Report Second Quarter 2020 Financial Results
August 06, 2020 16:05 ET
|
Progenity, Inc.
SAN DIEGO, Aug. 06, 2020 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing...
Progenity Reaches Resolution with Government Related to Past Business, Promotional, and Billing Practices
July 23, 2020 13:58 ET
|
Progenity, Inc.
SAN DIEGO, July 23, 2020 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company focused on providing complex molecular and specialized diagnostic tests to clinicians as well as...